Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Capponcelli

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Analyst|December 17, 2008
Split hybridisation probes for electrochemical typing of single-nucleotide polymorphismsFausto Lucarelli, Silvia Capponcelli, Giovanna Marrazza, et al.
Investigational New Drugs|May 4, 2005
A mutated p53 status did not prevent the induction of apoptosis by sulforaphane, a promising anti-cancer drugCarmela Fimognari, Luca Sangiorgi, Silvia Capponcelli, et al.
Human Mutation|August 10, 2005
Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromasElena Pedrini, Alessandro De Luca, Enza Maria Valente, et al.
Oncology Reports|June 7, 2003
Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstructionAmira Beccheroni, Enrico Lucarelli, Davide Donati, et al.
Human Mutation|June 25, 2005
Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutationSilvia Capponcelli, Elena Pedrini, Maria Antonietta Cerone, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Analyst|December 17, 2008
Split hybridisation probes for electrochemical typing of single-nucleotide polymorphismsFausto Lucarelli, Silvia Capponcelli, Giovanna Marrazza, et al.
Investigational New Drugs|May 4, 2005
A mutated p53 status did not prevent the induction of apoptosis by sulforaphane, a promising anti-cancer drugCarmela Fimognari, Luca Sangiorgi, Silvia Capponcelli, et al.
Human Mutation|August 10, 2005
Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromasElena Pedrini, Alessandro De Luca, Enza Maria Valente, et al.
Oncology Reports|June 7, 2003
Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstructionAmira Beccheroni, Enrico Lucarelli, Davide Donati, et al.
Human Mutation|June 25, 2005
Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutationSilvia Capponcelli, Elena Pedrini, Maria Antonietta Cerone, et al.
Pageof 1